Nvidia’s Anthropic Investment: Securing AI Demand Amid Rising Competition

Nvidia’s Anthropic Investment: Securing AI Demand Amid Rising Competition Vardah Gill Tue, September 15, 2026 at 4:28 PM GMT+2 6 min read NVDA MSFT On September 13, Reuters reported that Anthropic is in talks to bring NVIDIA Corporation (NASDAQ: NVDA ) in as an anchor investor in what could become one of the largest IPOs in history, potentially raising as much as $100 billion at a valuation of around $2 trillion. Nvidia is reportedly considering an investment of up to $10 billion. Anthropic's annualized revenue run rate has reportedly increased from about $9 billion in 2025 to more than $65 billion by mid-2026, with the company targeting as much as $200 billion of revenue by 2028.

The strategic significance for Nvidia is greater than the potential financial return from the investment: Anthropic is a major buyer and user of AI computing infrastructure, and Reuters reported that it has committed $30 billion to Microsoft Azure infrastructure powered by Nvidia chips. Anthropic is also pursuing major capacity agreements with other providers and developing custom chips, making its future hardware choices strategically important to Nvidia. The move would also deepen an already established relationship.

NVIDIA Corporation (NASDAQ:NVDA) has previously disclosed an investment and technology partnership with Anthropic, while its fiscal 2026 filing said it had entered into an agreement to invest up to $10 billion in Anthropic. Nvidia generated $215. 9 billion of fiscal 2026 revenue, up 65%, with Data Center revenue up 68%, demonstrating the enormous economic leverage of continued AI infrastructure spending.

Nvidia’s Anthropic Investment: Securing AI Demand Amid Rising Competition Anthropic's Rapid Growth Strengthens Nvidia's Long-Term Opportunity The strongest bullish argument is that an equity investment could help NVIDIA Corporation (NASDAQ:NVDA) protect and expand one of the fastest-growing sources of demand for its GPUs. Anthropic's reported annualized revenue growth from $9 billion to more than $65 billion in roughly 18 months implies a rapidly expanding need for training and inference capacity. Its reported $30 billion commitment to Microsoft Azure powered by Nvidia systems provides a particularly direct link between Anthropic's growth and Nvidia's infrastructure demand.

Anthropic is also reportedly committing $45 billion to rent AI computing capacity from Nscale, with that infrastructure expected to use Nvidia's Vera Rubin chips, indicating that the relationship can translate into future-generation hardware demand rather than being limited to Nvidia's existing products. The investment could also strengthen Nvidia's position as AI workloads shift from model training toward large-scale inference and agentic AI. Nvidia recently said Anthropic is evaluating its Vera CPU for CPU-intensive agentic workloads, while Nvidia has positioned Blackwell Ultra and the Vera Rubin platform around the rapidly expanding inference market.

Nvidia has disclosed visibility into more than $1 trillion of cumulative Blackwell and Rubin revenue from the beginning of 2025 through 2027, with Anthropic among the model developers contributing to that ecosystem. A successful Anthropic IPO would therefore potentially create a well-capitalized AI customer capable of financing much larger infrastructure deployments, while Nvidia could simultaneously benefit from the investment's financial upside. Story Continues There is also a strategic ecosystem benefit.

Anthropic is working with Amazon, Google, Microsoft, Nvidia and other infrastructure providers, while NVIDIA Corporation (NASDAQ:NVDA)'s investment gives it a closer economic relationship with a leading model developer rather than relying solely on selling hardware. That matters as hyperscalers and AI companies increasingly explore custom silicon. Nvidia's ability to remain deeply embedded in Anthropic's infrastructure roadmap could help defend its software-and-systems ecosystem against competing accelerators and custom chips.

The company's recent agreement with d-Matrix to integrate third-party inference processors through NVLink Fusion similarly shows Nvidia is attempting to make its architecture the broader platform around AI compute, rather than relying exclusively on selling GPUs. High Anthropic Valuation Raises the Stakes for Nvidia The principal risk is that NVIDIA Corporation (NASDAQ:NVDA) could be investing billions of dollars to support a customer whose long-term infrastructure strategy may increasingly diversify away from Nvidia GPUs. Reuters reported that Anthropic has partnerships with Amazon, Google and Broadcom and is developing custom chips to optimize hardware costs.

More recently, Anthropic agreed to purchase billions of dollars of AI servers from AMD, while Broadcom has been involved in efforts to develop custom AI chips for Anthropic. That creates a potential conflict for Nvidia: Anthropic's growth may be extremely positive for AI infrastructure demand overall while being less positive for Nvidia's share of that spending. If Anthropic becomes increasingly successful at using alternative accelerators or custom silicon, Nvidia's investment could effectively help finance the expansion of a customer that is simultaneously reducing its dependence on Nvidia hardware.

Valuation is another concern. A potential $10 billion investment at an implied Anthropic valuation approaching $2 trillion would require extraordinary future growth to generate attractive returns. Reuters reported that Anthropic's valuation had already reached $965 billion following its May 2026 financing, meaning the prospective IPO would represent a more than doubling of valuation in a relatively short period.

Nvidia therefore faces the risk of committing substantial capital at an exceptionally high private-market valuation, where even strong operational growth may not translate into equivalent investment returns. Nvidia itself has warned in regulatory filings that strategic investments can result in impairment losses or the loss of some or all invested capital and that capital allocated to such partnerships may not produce the anticipated strategic benefits. More importantly, the investment comes as the market is becoming increasingly sensitive to whether the enormous AI infrastructure buildout can continue at its current pace.

On September 14, Anthropic CEO Dario Amodei joined other AI leaders in calling for a slowdown in AI development because of safety concerns, contributing to a sharp selloff in AI-related stocks; the Philadelphia Semiconductor Index fell 5. 1% that day. Although this does not directly undermine Anthropic's demand, it highlights the valuation and spending risk surrounding the AI ecosystem.

NVIDIA Corporation (NASDAQ:NVDA)'s fiscal 2026 gross margin was already 71. 1%, down from the prior year, partly because of its transition toward full-scale Blackwell data-center systems and a $4. 5 billion charge related to H20 inventory and purchase obligations.

A large additional strategic investment could therefore expose Nvidia to both equity-valuation risk and the possibility that AI infrastructure spending normalizes faster than expected. Conclusion NVIDIA Corporation (NASDAQ:NVDA)'s potential Anthropic investment is strategically bullish but financially mixed. It could secure substantial future AI-chip demand and strengthen Nvidia's position in Anthropic's infrastructure roadmap, but Anthropic's growing use of AMD, custom chips, and other suppliers creates competitive risk.

Overall, the deal supports Nvidia's long-term growth and ecosystem position, but its high valuation and diversification risks limit the immediate upside. While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .

READ NEXT: Apollo and J&J Face a High-Stakes Orthopedics Deal and AstraZeneca's Oncology Engine Faces a Key Test After Camizestrant Miss This article is originally published at Insider Monkey .